NCT04800822 2024-10-22PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT00959127 2020-09-16A Study of ARRY-438162 (MEK162) in Patients With Advanced CancerArray BioPharmaPhase 1 Completed93 enrolled